Wolfram Hoetzenecker

8PUBLICATIONS
53CO-AUTHORS
Developmental genetics (incl. sex determination)Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2026
Darier disease-A review highlighting new insights from the Darier Disease International Task Force.

|Nov 28, 2024
Darier disease: Current insights and challenges in pathogenesis and management.

Monika Ettinger, Susanne Kimeswenger, Isabella Deli

|Aug 26, 2024
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade.

Julia Holzgruber, Christina Martins, Zsofi Kulcsar

|Jan 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.

Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger

|Nov 18, 2023
Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets.

Monika Ettinger, Teresa Burner, Anshu Sharma

|Nov 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.

Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe

Pageof 2